Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.38 - $0.64 $42,680 - $71,882
-112,316 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.55 - $0.98 $4,348 - $7,747
-7,906 Reduced 6.58%
112,316 $75,000
Q4 2021

Feb 11, 2022

SELL
$0.9 - $1.31 $3,237 - $4,712
-3,597 Reduced 2.91%
120,222 $119,000
Q3 2021

Nov 12, 2021

SELL
$1.21 - $1.61 $3,559 - $4,736
-2,942 Reduced 2.32%
123,819 $158,000
Q2 2021

Aug 13, 2021

SELL
$1.6 - $2.02 $5,142 - $6,492
-3,214 Reduced 2.47%
126,761 $207,000
Q1 2021

May 07, 2021

BUY
$1.86 - $2.87 $19,965 - $30,806
10,734 Added 9.0%
129,975 $257,000
Q4 2020

Feb 12, 2021

SELL
$1.65 - $2.43 $3,052 - $4,495
-1,850 Reduced 1.53%
119,241 $247,000
Q3 2020

Nov 04, 2020

BUY
$1.6 - $2.35 $214 - $314
134 Added 0.11%
121,091 $207,000
Q2 2020

Aug 12, 2020

BUY
$1.33 - $2.76 $160,872 - $333,841
120,957 New
120,957 $281,000
Q2 2019

Aug 13, 2019

SELL
$0.51 - $0.86 $50,977 - $85,961
-99,955 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$0.51 - $0.82 $1,651 - $2,655
-3,239 Reduced 3.14%
99,955 $63,000
Q4 2018

Feb 13, 2019

SELL
$0.48 - $1.1 $381 - $873
-794 Reduced 0.76%
103,194 $50,000
Q3 2018

Nov 09, 2018

BUY
$1.06 - $1.69 $1,987 - $3,168
1,875 Added 1.84%
103,988 $114,000
Q2 2018

Aug 08, 2018

BUY
$1.56 - $2.51 $16,233 - $26,119
10,406 Added 11.35%
102,113 $159,000
Q1 2018

May 07, 2018

SELL
$0.91 - $2.24 $4,488 - $11,047
-4,932 Reduced 5.1%
91,707 $196,000
Q4 2017

Feb 09, 2018

BUY
$0.78 - $2.1 $3,678 - $9,903
4,716 Added 5.13%
96,639 $89,000
Q3 2017

Nov 09, 2017

BUY
$1.55 - $1.82 $142,480 - $167,299
91,923
91,923 $163,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $294M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.